1. Arena’s APD418 Receives FDA’s Fast Track Designation to Treat Patients with Decompensated Heart Failure Published: Jan 17, 2020 | Tags: Arena, APD418, Receives, FDA, Fast Track Designation, Treat, Patients, Decompensated […]readmore
Tags : JT
Shots: Dermavant to receive $60M up front, up to $53M as development milestones and royalties on sales of the tapinarof in psoriasis and AD. JT and its subsidiary, Torii Pharmaceutical […]readmore